Waterdrop Inc. has been included in Harvard Business school’s (HBS) Case Collection. Inducted as a business innovation case, ...

Studies presented at the Society of Neurointerventional Surgery’s show links between GLP-1s and the prevention of strokes and ...

Industry stakeholders suggest how pharmaceutical companies can proactively plan for the potential implementation of a Most Favored Nation (MFN) pricing model.

Dr. Ben Zeskind, CEO of Immuneering, discusses the new approach his company is taking to oncology.